{"id":"W4381250197","doi":"10.3390/curroncol30060439","title":"Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Atezolizumab; Bevacizumab; Liver transplantation; Immune system; Tumor microenvironment; Cancer research; Liver disease; Immunotherapy; Immune checkpoint; Colorectal cancer; Immunology; Inflammation; Cancer; Oncology; Transplantation; Internal medicine; Chemotherapy; Nivolumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005732319,0.0005875721,0.0009485426,0.00133073,0.0001909373,0.0007500609,0.0007824412,0.0007439741,0.00435093],"category_scores_gemma":[0.0006622846,0.0001948399,0.0006222557,0.001074233,0.0002205056,0.0009648564,0.0004634877,0.001766318,0.001854618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005081251,"about_ca_system_score_gemma":0.0007007335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000682,"about_ca_topic_score_gemma":0.001885366,"domain_scores_codex":[0.9998325,0.00003271077,0.00002778845,0.0000256623,0.00006469812,0.00001655748],"domain_scores_gemma":[0.9997315,0.0001226683,0.00004277207,0.000006761356,0.00007191166,0.00002437985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007266594,0.00004385815,0.00008679186,0.008527687,0.00006807694,0.0000625279,0.00002102497,0.0002278356,0.0005751651,0.001310865,0.02619093,0.9628126],"study_design_scores_gemma":[0.0000393061,0.000131761,0.0007388719,0.005076711,0.0001711326,0.0005866623,0.00002625792,0.0001350038,0.0002365739,0.00133803,0.9915065,0.00001322123],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001161095,0.9980822,0.00009009638,0.0004310838,0.0002264533,0.000006416955,0.00002142879,0.00001072978,0.001015546],"genre_scores_gemma":[0.0007141354,0.9978392,0.0001526953,0.0003958195,0.0002150792,0.00001015125,0.00004809467,0.000001764686,0.0006231874],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00435093,"threshold_uncertainty_score":0.01455534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2003887597590895,"score_gpt":0.436491776261539,"score_spread":0.2361030165024494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}